Central Nervous System Tuberculosis

被引:104
|
作者
Leonard, John M. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med Infect Dis, Nashville, TN 37232 USA
来源
MICROBIOLOGY SPECTRUM | 2017年 / 5卷 / 02期
关键词
INTRACRANIAL TUBERCULOMA; MYCOBACTERIUM-TUBERCULOSIS; MENINGITIS; DIAGNOSIS; ADULTS; CT; DEXAMETHASONE; CHEMOTHERAPY; MANAGEMENT; CHILDREN;
D O I
10.1128/microbiolspec.TNMI7-0044-2017
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Central nervous system tuberculosis (CNS-TB) takes three clinical forms: meningitis (TBM), intracranial tuberculoma, and spinal arachnoiditis. TBM predominates in the western world and presents as a subacute to chronic meningitis syndrome with a prodrome of malaise, fever, and headache progressing to altered mentation and focal neurologic signs, followed by stupor, coma, and death within five to eight weeks of onset. The CSF formula typically shows a lymphocytic pleocytosis, and low glucose and high protein concentrations. Diagnosis rests on serial samples of CSF for smear and culture, combined with CSF PCR. Brain CT and MRI aid in diagnosis, assessment for complications, and monitoring of the clinical course. In a patient with compatible clinical features, the combination of meningeal enhancement and any degree of hydrocephalus is strongly suggestive of TBM. Vasculitis leading to infarcts in the basal ganglia occurs commonly and is a major determinant of morbidity and mortality. Treatment is most effective when started in the early stages of disease, and should be initiated promptly on the basis of strong clinical suspicion without waiting for laboratory confirmation. The initial 4 drug regimen (isoniazid, rifampin, pyrazinamide, ethambutol) covers the possibility of infection with a resistant strain, maximizes antimicrobial impact, and reduces the likelihood of emerging resistance on therapy. Adjunctive corticosteroid therapy has been shown to reduce morbidity and mortality in all but late stage disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Risk Factors for Central Nervous System Tuberculosis
    Duque-Silva, Alexandra
    Robsky, Katherine
    Flood, Jennifer
    Barry, Pennan M.
    PEDIATRICS, 2015, 136 (05) : E1276 - E1284
  • [22] CENTRAL NERVOUS SYSTEM TUBERCULOSIS - PERSISTENT DISEASE
    WILKINSON, HA
    FERRIS, EJ
    MUGGIA, AL
    CANTU, RC
    JOURNAL OF NEUROSURGERY, 1971, 34 (01) : 15 - +
  • [23] A Rare Case of Central Nervous System Tuberculosis
    Parekh, Ravish
    Haftka, Alexis
    Porter, Ashleigh
    CASE REPORTS IN INFECTIOUS DISEASES, 2014, 2014
  • [24] Central nervous system tuberculosis after resolution of miliary tuberculosis
    Chang, AB
    Grimwood, K
    Harvey, AS
    Rosenfeld, JV
    Olinsky, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (06) : 519 - 523
  • [25] Tuberculosis of the central nervous system and literature review
    Abdelkafi, N.
    Aissi, M.
    Bouatay, F.
    Mahmoud, I.
    Khalfaoui, S.
    Ayed-Frih, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E109 - E109
  • [26] Mortality associated with central nervous system tuberculosis
    El Sahly, Hana M.
    Teeter, Larry D.
    Pan, Xi
    Musser, James M.
    Graviss, Edward A.
    JOURNAL OF INFECTION, 2007, 55 (06) : 502 - 509
  • [27] CENTRAL-NERVOUS-SYSTEM TUBERCULOSIS - MRI
    KIOUMEHR, F
    DADSETAN, MR
    ROOHOLAMINI, SA
    AU, A
    NEURORADIOLOGY, 1994, 36 (02) : 93 - 96
  • [28] CENTRAL-NERVOUS-SYSTEM TUBERCULOSIS IN CHILDREN
    CURLESS, RG
    MITCHELL, CD
    PEDIATRIC NEUROLOGY, 1991, 7 (04) : 270 - 274
  • [29] The Many Faces of Central Nervous System Tuberculosis
    Cardenas, Graciela
    Luis Soto-Hernandez, Jose
    ARCHIVES OF NEUROLOGY, 2011, 68 (08) : 1078 - 1079
  • [30] Central Nervous System Tuberculosis A Forgotten Diagnosis
    Chou, Ping-Song
    Liu, Ching-Kuan
    Lin, Ruey-Tay
    Lai, Chiou-Lian
    Chao, A-Ching
    NEUROLOGIST, 2012, 18 (04) : 219 - 222